These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 9312186)

  • 21. The xerocytosis of Hb SC disease.
    Ballas SK; Larner J; Smith ED; Surrey S; Schwartz E; Rappaport EF
    Blood; 1987 Jan; 69(1):124-30. PubMed ID: 2947642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disruption of erythroid K-Cl cotransporters alters erythrocyte volume and partially rescues erythrocyte dehydration in SAD mice.
    Rust MB; Alper SL; Rudhard Y; Shmukler BE; Vicente R; Brugnara C; Trudel M; Jentsch TJ; Hübner CA
    J Clin Invest; 2007 Jun; 117(6):1708-17. PubMed ID: 17510708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. KCl cotransport activity in light versus dense transferrin receptor-positive sickle reticulocytes.
    Franco RS; Palascak M; Thompson H; Joiner CH
    J Clin Invest; 1995 Jun; 95(6):2573-80. PubMed ID: 7769099
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Erythrocyte composition in sickle-cell anemia.
    Hellerstein S; Bunthrarungroj T
    J Lab Clin Med; 1974 Apr; 83(4):611-24. PubMed ID: 4817782
    [No Abstract]   [Full Text] [Related]  

  • 25. The clinical pathophysiology of sickle cell disease.
    Embury SH
    Annu Rev Med; 1986; 37():361-76. PubMed ID: 2423018
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment with oral clotrimazole blocks Ca(2+)-activated K+ transport and reverses erythrocyte dehydration in transgenic SAD mice. A model for therapy of sickle cell disease.
    De Franceschi L; Saadane N; Trudel M; Alper SL; Brugnara C; Beuzard Y
    J Clin Invest; 1994 Apr; 93(4):1670-6. PubMed ID: 7512989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination therapy of erythropoietin, hydroxyurea, and clotrimazole in a beta thalassemic mouse: a model for human therapy.
    de Franceschi L; Rouyer-Fessard P; Alper SL; Jouault H; Brugnara C; Beuzard Y
    Blood; 1996 Feb; 87(3):1188-95. PubMed ID: 8562946
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined genetic disruption of K-Cl cotransporters and Gardos channel KCNN4 rescues erythrocyte dehydration in the SAD mouse model of sickle cell disease.
    Shmukler BE; Rivera A; Bhargava P; Nishimura K; Hsu A; Kim EH; Trudel M; Rust MB; Hubner CA; Brugnara C; Alper SL
    Blood Cells Mol Dis; 2019 Nov; 79():102346. PubMed ID: 31352162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bepridil protects sickle cells against the adverse rheological effects of cyclical deoxygenation.
    Johnston MN; Ellory JC; Stuart J
    Br J Haematol; 1989 Dec; 73(4):522-6. PubMed ID: 2611138
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of K+ efflux and dehydration of sickle cells by [(dihydroindenyl)oxy]alkanoic acid: an inhibitor of the K+ Cl- cotransport system.
    Vitoux D; Olivieri O; Garay RP; Cragoe EJ; Galacteros F; Beuzard Y
    Proc Natl Acad Sci U S A; 1989 Jun; 86(11):4273-6. PubMed ID: 2726772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of erythrocyte cation and water content in sickle cell anemia.
    Brugnara C; Bunn HF; Tosteson DC
    Science; 1986 Apr; 232(4748):388-90. PubMed ID: 3961486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sodium-potassium pump, ion fluxes, and cellular dehydration in sickle cell anemia.
    Izumo H; Lear S; Williams M; Rosa R; Epstein FH
    J Clin Invest; 1987 Jun; 79(6):1621-8. PubMed ID: 3034977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of Ca(2+)-dependent K+ transport and cell dehydration in sickle erythrocytes by clotrimazole and other imidazole derivatives.
    Brugnara C; de Franceschi L; Alper SL
    J Clin Invest; 1993 Jul; 92(1):520-6. PubMed ID: 8326017
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of glyceraldehyde on the structural and functional properties of sickle erythrocytes.
    Nigen AM; Manning JM
    J Clin Invest; 1978 Jan; 61(1):11-9. PubMed ID: 618907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New insights provided by a comparison of impaired deformability with erythrocyte oxidative stress for sickle cell disease.
    Barodka VM; Nagababu E; Mohanty JG; Nyhan D; Berkowitz DE; Rifkind JM; Strouse JJ
    Blood Cells Mol Dis; 2014 Apr; 52(4):230-5. PubMed ID: 24246527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oxpentifylline and cetiedil citrate improve deformability of dehydrated sickle cells.
    Stuart J; Stone PC; Bilto YY; Keidan AJ
    J Clin Pathol; 1987 Oct; 40(10):1182-6. PubMed ID: 3119675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transmembrane cationic fluxes in erythrocytes of diabetics and normal men.
    Lijnen P; Fenyvesi A
    Methods Find Exp Clin Pharmacol; 1994; 16(1):37-47. PubMed ID: 8164472
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of K-Cl cotransport during reticulocyte maturation and erythrocyte aging in normal and sickle erythrocytes.
    Bize I; Taher S; Brugnara C
    Am J Physiol Cell Physiol; 2003 Jul; 285(1):C31-8. PubMed ID: 12606312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Established and experimental treatments for sickle cell disease.
    De Franceschi L; Corrocher R
    Haematologica; 2004 Mar; 89(3):348-56. PubMed ID: 15020275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Erythrocyte disorders leading to potassium loss and cellular dehydration.
    Glader BE; Sullivan DW
    Prog Clin Biol Res; 1979; 30():503-13. PubMed ID: 531041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.